166 filings
Page 3 of 9
8-K
9rzx4k2 so36s7fk2
16 Mar 20
Regulation FD Disclosure
6:16am
8-K
ng7ibt lou0z
13 Feb 20
Results of Operations and Financial Condition
7:05am
8-K
ar5a23 jio46qlw
13 Jan 20
1 J.P. Morgan 38 th Annual Healthcare Conference Ironwood Pharmaceuticals January 2020
8:31am
8-K
j1j9ik gb
31 Oct 19
Results of Operations and Financial Condition
7:06am
8-K
q0t ednvt
18 Sep 19
Entry into a Material Definitive Agreement
8:00am
8-K
uruk6nyj xe
16 Sep 19
Termination of a Material Definitive Agreement
5:12pm
8-K
vt0assge
14 Aug 19
Entry into a Material Definitive Agreement
12:00am
8-K
9n4vi5r0085
13 Aug 19
Entry into a Material Definitive Agreement
5:20pm
8-K
efe4rqsjbi77y
1 Aug 19
Entry into a Material Definitive Agreement
4:22pm
8-K
sl2ddf98o2 yyvpct6k
30 Jul 19
Ironwood Pharmaceuticals Reports Second Quarter 2019 Results
4:05pm
8-K
ygq0 kek3
22 Jul 19
Other Events
4:04pm
8-K
ghjwllqrj ph
10 Jul 19
Departure of Directors or Certain Officers
4:00pm
8-K
1dsi3q sjujds5l
13 Jun 19
Ironwood Pharmaceuticals to Establish New Headquarters in Downtown Boston
4:37pm
8-K
bwx fn8qc
31 May 19
Material Modifications to Rights of Security Holders
4:05pm
8-K
5o69idav4
14 May 19
Results of Operations and Financial Condition
8:00am
8-K/A
95i9jffezgc
3 May 19
Departure of Directors or Certain Officers
4:06pm
8-K
8vgz2al
2 May 19
Ironwood Pharmaceuticals Reports First Quarter 2019 Results; Announces Positive 2019 Adjusted EBITDA from Continuing Operations Guidance
7:45am
8-K
wr0pk41tv zhzof93i3j
8 Apr 19
Entry into a Material Definitive Agreement
4:45pm
8-K
e9th x7hniee4f
4 Apr 19
Ironwood Pharmaceuticals Completes Separation of Cyclerion Therapeutics and Becomes a Gastrointestinal (GI)-focused Healthcare Company
4:46pm
8-K
k0vpplce
2 Apr 19
Other Events
9:15am